Persistent inflammation may influence neurodegeneration through microglial activation, yet evidence remains hypothesis driven ...

Adults with primary membranous nephropathy achieved higher complete remission rates with obinutuzumab than tacrolimus in the pivotal phase 3 MAJESTY trial.

Researchers have uncovered a new way to attack lymphoma by targeting a non-catalytic region of a key regulatory enzyme, rather than its traditional active site. Researchers at VCU Massey Comprehensive ...

On Friday, the U.S. Food and Drug Administration (FDA) approved AbbVie Inc.'s ABBV combination treatment for chronic ...

Vassili Cremanzidis, a beloved figure in football and soccer, passed away at 36, leaving the sports world heartbroken. His legacy as a strategist and fan lives on.

“Facial lymphatic brushing gently stimulates lymph flow, helping to move excess fluid, reduce puffiness, and support the skin ...

Mir195 enables Ebf1-deficient hematopoietic progenitor cells to mature into B cells, suggesting some miRNA can substitute for transcription factors in differentiation.

Bayer proposes a $7.25 billion settlement to resolve Roundup lawsuits over non-Hodgkin lymphoma, expanding its legal ...

Daiichi Sankyo begins patient dosing in phase 1/2 trial of DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: Tokyo Friday, February 6, 2026, 10:00 Hrs [I ...

Kasey Keller, the USMNT goalkeeper through four FIFA World Cups, discusses his non-Hodgkins lymphoma diagnosis in 2010 and what the soccer legend has gone through since.